Phosphoinositide-3-kinase inhibition induces sodium/iodide symporter expression in rat thyroid cells and human papillary thyroid cancer cells

Journal of Endocrinology

Volumn 199, Issue 2, 2008, Pages 243-252

  Kogai, Takahiko ^a   Sajid Crockett, Saima ^a   Newmarch, Lynell S ^a   Liu, Yan Yun ^a   Brent, Gregory A ^a,b  

^a VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; CYCLOHEXIMIDE; INSULIN; IODIDE; MESSENGER RNA; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PROTEIN KINASE B; RADIOACTIVE IODINE; SODIUM IODIDE SYMPORTER; TRANSCRIPTION FACTOR PAX8;

ANAPLASTIC CARCINOMA; ANIMAL CELL; ARTICLE; CANCER CELL; CONTROLLED STUDY; ENZYME INHIBITION; GENE EXPRESSION REGULATION; GENE INDUCTION; HUMAN; HUMAN CELL; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; RAT; THYROID CELL; THYROID PAPILLARY CARCINOMA; TRANSCRIPTION REGULATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; BLOTTING, WESTERN; CELL LINE; CELL LINE, TUMOR; CHROMONES; CYCLOHEXIMIDE; GENE EXPRESSION; HUMANS; IODIDES; MORPHOLINES; ONCOGENE PROTEIN V-AKT; PAIRED BOX TRANSCRIPTION FACTORS; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SYMPORTERS; THYROID GLAND; THYROID NEOPLASMS;

EID: 56849115726     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1677/JOE-08-0333     Document Type: Article

References (35)

1. Abramoff MD, Magelhaes PJ & Ram SJ 2004 Image processing with Image. J Biophotonics International 11 36-42.
2. Dohan O, Baloch Z, Banrevi Z, Livolsi V & Carrasco N 2001 Rapid communication: predominant intracellular overexpression of the Na(+)/ I(-) symporter (NIS) in a large sampling of thyroid cancer cases. Journal of Clinical Endocrinology and Metabolism 86 2697-2700.
3. El-Kholy W, Macdonald PE, Lin JH, Wang J, Fox JM, Light PE, Wang Q, Tsushima RG & Wheeler MB 2003 The phosphatidylinositol 3-kinase inhibitor LY294002 potently blocks K(V) currents via a direct mechanism. FASEB Journal 17 720-722.
4. Endo T, Kaneshige M, Nakazato M, Ohmori M, Harii N & Onaya T 1997 Thyroid transcription factor-1 activates the promoter activity of rat thyroid Na +/I- symporter gene. Molecular Endocrinology 11 1747-1755.
5. Furuya F, Lu C, Willingham MC & Cheng SY 2007 Inhibition of phosphatidylinositol 3-kinase delays tumor progression and blocks metastatic spread in a mouse model of thyroid cancer. Carcinogenesis 28 2451-2458.
6. Garcia B & Santisteban P 2002 PI3K is involved in the IGF-I inhibition of TSH-induced sodium/iodide symporter gene expression. Molecular Endocrinology 16 342-352.
7. Gharbi SI, Zvelebil MJ, Shuttleworth SJ, Hancox T, Saghir N, Timms JF & Waterfield MD 2007 Exploring the specificity of the PI3K family inhibitor LY294002. Biochemical Journal 404 15-21.
8. Giuliani C, Noguchi Y, Harii N, Napolitano G, Tatone D, Bocci I, Piantelli M, Monaco F & Kohn LD 2007 The flavonoid quercetin regulates growth and gene expression in rat Frtl-5 thyroid cells. Endocrinology 149 84-92.
9. Hou P, Liu D, Ji M & Xing M 2007 Potent inhibition of thyroid cancer cells and reexpression of thyroid genes by dual knockdown of the PI3K/ Akt and MAP kinase pathways. In American Thyroid Association, 78th Annual Meeting, pp S-105. New York.
10. Knight ZA, Gonzalez B, Feldman ME, Zunder ER, Goldenberg DD, Williams O, Loewith R, Stokoe D, Balla A, Toth B et al. 2006 A pharmacological map of the PI3-K family defines a role for p 110α in insulin signaling. Cell 125 733-747.
11. Knostman KA, McCubrey JA, Morrison CD, Zhang Z, Capen CC & Jhiang SM 2007 PI3K activation is associated with intracellular sodium/iodide symporter protein expression in breast cancer. BMC Cancer 7 137.
12. Kogai T, Endo T, Saito T, Miyazaki A, Kawaguchi A & Onaya T 1997 Regulation by thyroid-stimulatmg hormone of sodium/iodide symporter gene expression and protein levels in FRTL-5 cells. Endocrinology 138 2227-2232.
13. Kogai T, Schultz JJ, Johnson LS, Huang M & Brent GA 2000 Retinoic acid induces sodium/iodide symporter gene expression and radioiodide uptake in the MCF-7 breast cancer cell line. PNAS 97 8519-8524.
14. Kogai T, Hershman JM, Motomura K, Endo T, Onaya T & Brent GA 2001 Differential regulation of the human sodium/iodide symporter gene promoter in papillary thyroid carcinoma cell lines and normal thyroid cells. Endocrinology 142 3369-3379.
15. Kogai T, Kanamoto Y, Li AI, Che LH, Ohashi E, Taki K, Chandraratna RA, Saito T & Brent GA 2005 Differential regulation of sodium/iodide symporter (NIS) gene expression by nuclear receptor ligands in MCF-7 breast cancer cells. Endocrinology 146 3059-3069.
16. Kogai T, Taki K & Brent GA 2006 Enhancement of sodium/iodide symporter expression in thyroid and breast cancer. Endocrine-Related Cancer 13 797-826.
17. Kogai T, Ohashi E, Jacobs MS, Sajid-Crockett S, Fisher ML, Kanamoto Y & Brent GA 2008 Retinoic acid stimulation of the sodium/iodide symporter in MCF-7 breast cancer cells is meditated by the insulin growth factor-i/ phosphatidylinositol 3-kinase and p38 mitogen-activated protein kinase signaling pathways. Journal of Clinical Endocrinology and Metabolism 93 1884-1892.
18. Kosugi S, Sasaki N, Hai N, Sugawa H, Aoki N, Shigemasa C, Mori T & Yoshida A 1996 Establishment and characterization of a Chinese hamster ovary cell line, CHO-4J, stably expressing a number of Na +/I - symporters. Biochemical and Biophysical Research Communications 227 94-101.
19. Levy O, De la Vieja A, Ginter CS, Riedel C, Dai G & Carrasco N 1998 N-linked glycosylation of the thyroid Na+/I- symporter (NIS). Implications for its secondary structure model. Journal of Biological Chemistry 273 22657-22663.
20. Miyagi E, Braga-Basaria M, Hardy E, Vasko V, Burman KD, Jhiang S, Saji M & Ringel MD 2004 Chronic expression of RET/PTC 3 enhances basal and insulin-stimulated PI3 kinase/AKT signaling and increases IRS-2 expression in FRTL-5 thyroid cells. Molecular Carcinegenesis 41 98-107.
21. Ohmori M, Endo T, Harii N & Onaya T 1998 A novel thyroid transcription factor is essential for thyrotropin-induced up-regulation of Na +/I- symporter gene expression. Molecular Endocrinology 12 727-736.
22. Ohno M, Zannini M, Levy O, Carrasco N & di Lauro R 1999 The paired-domain transcription factor Pax8 binds to the upstream enhancer of the rat sodium/iodide symporter gene and participates in both thyroid-specific and cyclic-AMP-dependent transcription. Molecular and Cellular Biology 19 2051-2060.
23. Puppin C, D'Aurizio F, D'Elia AV, Cesaratto L, Tell G, Russo D, Filetti S, Ferretti E, Tosi E, Mattei T et al. 2005 Effects of histone acetylation on sodium iodide symporter promoter and expression of thyroid-specific transcription factors. Endocrinology 146 3967-3974.
24. Riedel C, Levy O & Carrasco N 2001 Post-transcriptional regulation of the sodium/iodide symporter by thyrotropin. Journal of Biological Chemistry 276 21458-21463.
25. Riesco-Eizaguirre G, Gutierrez-Martinez P, Garcia-Cabezas MA, Nistal M & Santisteban P 2006 The oncogene BRAF V600E is associated with a high risk of recurrence and less differentiated papillary thyroid carcinoma due to the impairment of Na +/I - targeting to the membrane. Endocrine-Related Cancer 13 257-269.
26. Saito T, Endo T, Kawaguchi A, Ikeda M, Nakazato M, Kogai T & Onaya T 1997 Increased expression of the Na+/I - symporter in cultured human thyroid cells exposed to thyrotropin and in Graves' thyroid tissue. Journal of Clinical Endocrinology and Metabolism 82 3331-3336.
27. Saito T, Endo T, Kawaguchi A, Ikeda M, Katoh R, Kawaoi A, Muramatsu A & Onaya T 1998 Increased expression of the sodium/iodide symporter in papillary thyroid carcinomas. Journal of Clinical Investigation 101 1296-1300.
28. Saji M & Kohn LD 1991 Insulin and insulin-like growth factor-I inhibit thyrotropin-increased iodide transport in serum-depleted FRTL-5 rat thyroid cells: modulation of adenosine 3′,5′-monophosphate signal action. Endocrinology 128 1136-1143.
29. Schlumberger MJ 1998 Papillary and follicular thyroid carcinoma. New England Journal of Medicine 338 297-306.
30. Schmutzler C, Winzer R, Meissner-Weigl J & Kohrle J 1997 Retinoic acid increases sodium/iodide symporter mRNA levels in human thyroid cancer cell lines and suppresses expression of functional symporter in nontransformed FRTL-5 rat thyroid cells. Biochemical and Biophysical Research Communications 240 832-838.
31. Shimura H, Haraguchi K, Miyazaki A, Endo T & Onaya T 1997 Iodide uptake and experimental 131I therapy in transplanted undifferentiated thyroid cancer cells expressing the Na+/I- symporter gene. Endocrinology 138 4493-4496.
32. Taki K, Kogai T, Kanamoto Y, Hershman JM & Brent GA 2002 A thyroid-specific far-upstream enhancer in the human sodium/iodide symporter gene requires Pax-8 binding and cyclic adenosine 3′,5′-monophosphate response element-like sequence binding proteins for full activity and is differentially regulated in normal and thyroid cancer cells. Molecular Endocrinology 16 2266-2282.
33. Venkataraman GM, Yatin M, Marcinek R & Ain KB 1999 Restoration of iodide uptake in dedifferentiated thyroid carcinoma: relationship to human Na +/ I - symporter gene methylation status. Journal of Clinical Endocrinology and Metabolism 84 2449-2457.
34. Vitagliano D, Carlomagno F, Motti ML, Viglietto G, Nikiforov YE, Nikiforova MN, Hershman JM, Ryan AJ, Fusco A, Melillo RM et al. 2004 Regulation of p27Kip1 protein levels contributes to mitogenic effects of the RET/PTC kinase in thyroid carcinoma cells. Cancer Research 64 3823-3829.
35. Zaballos MA, Garcia B & Santisteban P 2008 Gβγ dimers released in response to thyrotropin activate phosphomositide 3-kinase and regulate gene expression in thyroid cells. Molecular Endocrinology 22 1183-1199.